Nancy A. Simonian - 01 Apr 2022 Form 4 Insider Report for Syros Pharmaceuticals, Inc. (SYRS)

Role
President & CEO, Director
Signature
/s/ Nancy Simonian
Issuer symbol
SYRS
Transactions as of
01 Apr 2022
Net transactions value
-$65,949
Form type
4
Filing time
04 Apr 2022, 17:02:10 UTC
Previous filing
04 Mar 2022
Next filing
17 May 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SYRS Common Stock Tax liability $65,949 -58,883 -7.8% $1.12 692,723 01 Apr 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares used to cover tax withholding on a Restricted Stock Unit release.
F2 Includes 129,117 shares of common stock released from the Restricted Stock Unit award reported on a Form 4 dated February 14, 2019.